Professor Graham Lord, from The University of Manchester, led the study, which could translate into treatments for autoimmune diseases including Cancer, Diabetes, Multiple Sclerosis and Crohn's Disease within a few years.
It is published in the Journal of Clinical Investigation today.
Discovery - Pathway - Molecule - MicroRNA-142 - Advance
The discovery of the molecular pathway regulated by a tiny molecule -- known as microRNA-142 -- is a major advance in our understanding of the immune system.
The 10-year-study found that microRNA-142 controls Regulatory T cells, which modulate the immune system and prevent autoimmune disease. It is, they found, the most highly expressed regulator in the immune system.
Professor - Lord - Research - Kings - College
Professor Lord, led the research while at Kings College London in collaboration with Professor Richard Jenner at UCL.
And according to Professor Lord, the discovery could be translated into a viable drug treatment within a few years.
Autoimmune - Diseases - People - Prime - Life
He said: "Autoimmune diseases often target people in the prime of their life creating a significant socio-economic burden on them. Sometimes, the effect can be devastating, causing terrible hardship and suffering.
"But these findings represent a significant step forward in the understanding of the immune system and we believe many people worldwide...
Wake Up To Breaking News!